Does methylphenidate normalize the classroom performance of children with attention deficit disorder?

Area of Science:

• Pediatric Psychology
• Neurodevelopmental Disorders
• Pharmacological Interventions

Background:

• Attention Deficit Disorder (ADD) significantly impacts children's classroom behavior and academic success.
• Methylphenidate (MPH) is a common stimulant medication used to manage ADD symptoms.
• Understanding MPH's efficacy in normalizing classroom functioning is crucial for treatment optimization.

Purpose of the Study:

• To evaluate the extent to which methylphenidate (MPH) normalizes classroom behavior and academic functioning in children with ADD.
• To compare the effects of MPH on ADD children's performance against normal control children.
• To identify individual-level responses to MPH treatment.

Main Methods:

• Double-blind, placebo-controlled trial involving 31 children diagnosed with ADD.
• Administration of four doses of MPH (5, 10, 15, 20 mg) and placebo.
• Assessment using teacher ratings, direct on-task behavior observations, and academic efficiency measures.

Main Results:

• MPH significantly improved attention and academic efficiency in children with ADD at a group level, bringing their performance to the level of normal controls.
• At the individual level, 25% of children with ADD did not achieve normalized classroom performance with MPH treatment.
• Significant differences were observed between ADD children treated with MPH and normal control children on specific classroom measures.

Conclusions:

• Methylphenidate (MPH) demonstrates group-level efficacy in normalizing classroom behavior and academic functioning for children with ADD.
• A notable percentage of children with ADD do not fully normalize their classroom performance with MPH alone.
• The findings suggest the necessity of integrating school-based interventions alongside MPH treatment for comprehensive ADD management.